# A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China

> **NCT02600221** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 2016 (actual)

## Conditions studied

- Asthma-COPD Overlap Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02600221
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-22
- **Primary completion:** 2016-10-24
- **Final completion:** 2016-10-24
- **Target enrollment:** 2016 (ACTUAL)
- **Last updated:** 2017-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02600221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02600221, "A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02600221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*